Veradermics (MANE) Total Liabilities (2024 - 2026)

Veradermics (MANE) has 3 years of Total Liabilities data on file, last reported at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 88.93% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (down 88.93% YoY), and the FY2025 full-year result was $9.2 million, up 94.07% from the prior year.
• Total Liabilities for Q1 2026 stood at $6.7 million, down from $9.2 million in the prior quarter.
• Across five years, Total Liabilities topped out at $60.7 million in Q1 2025 and bottomed at $4.7 million in Q4 2024.
• The 3-year median for Total Liabilities is $7.9 million (2025), against an average of $20.3 million.
• The widest annual swing landed in 2025, when Total Liabilities jumped 94.07%; it then sank 88.93% in 2026.
• A 3-year view of Total Liabilities shows it stood at $4.7 million in 2024, then surged by 94.07% to $9.2 million in 2025, then fell by 26.65% to $6.7 million in 2026.
• The last three Total Liabilities figures came in at $6.7 million (Q1 2026), $9.2 million (Q4 2025), and $60.7 million (Q1 2025), per Business Quant data.

Peer Comparison